ConcertAI subsidiary TeraRecon has formed a strategic partnership with AI software developer Gleamer.
As a result, TeraRecon will integrate Gleamer's BoneView (FDA-cleared and CE-marked versions) and ChestView software into its Eureka Clinical AI platform, according to the vendor. BoneView is cleared in the U.S. and Europe and is designed to identify bone fractures on x-rays, while ChestView is cleared in Europe and is designed to detect pulmonary nodules on x-rays.
